FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers; Commission Approves Final Consent Order in Matter of Dow Chemical Company and Rohm & Haas Company

FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers – Federal Trade Commission staff filed a comment stating that provisions of New York State Senate Bill 58 would likely have the unintended consequence of increasing prices that New York consumers and health plans pay […]

FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers; Commission Approves Final Consent Order in Matter of Dow Chemical Company and Rohm & Haas Company

FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers – Federal Trade Commission staff filed a comment stating that provisions of New York State Senate Bill 58 would likely have the unintended consequence of increasing prices that New York consumers and health plans pay […]